Nxera Pharma Co., Ltd. (SOLTF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 09:37AM EDT
Currency in USD
Valuation Measures4
| Market Cap (intraday) | 845.85M |
| Enterprise Value | 1.00B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 9.69 |
| Price/Book (mrq) | 2.01 |
| Enterprise Value/Revenue | 0.08 |
| Enterprise Value/EBITDA | -0.18 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 0.57 |
| 52-Week Change 3 | -50.66% |
| S&P500 52-Week Change 3 | 21.61% |
| 52 Week High 3 | 22.78 |
| 52 Week Low 3 | 8.56 |
| 50-Day Moving Average 3 | 10.06 |
| 200-Day Moving Average 3 | 10.34 |
Share Statistics
| Avg Vol (3 month) 3 | 887 |
| Avg Vol (10 day) 3 | 40 |
| Shares Outstanding 5 | 89.45M |
| Implied Shares Outstanding 6 | 90.8M |
| Float 8 | 66.49M |
| % Held by Insiders 1 | 11.12% |
| % Held by Institutions 1 | 42.77% |
| Shares Short 4 | N/A |
| Short Ratio 4 | N/A |
| Short % of Float 4 | N/A |
| Short % of Shares Outstanding 4 | N/A |
| Shares Short (prior month ) 4 | N/A |
Dividends & Splits
| Forward Annual Dividend Rate 4 | N/A |
| Forward Annual Dividend Yield 4 | N/A |
| Trailing Annual Dividend Rate 3 | 0.00 |
| Trailing Annual Dividend Yield 3 | 0.00% |
| 5 Year Average Dividend Yield 4 | N/A |
| Payout Ratio 4 | 0.00% |
| Dividend Date 3 | N/A |
| Ex-Dividend Date 4 | Mar 27, 2015 |
| Last Split Factor 2 | 100:1 |
| Last Split Date 3 | Mar 27, 2013 |
Financial Highlights
Currency in JPY.Fiscal Year
| Fiscal Year Ends | Dec 31, 2023 |
| Most Recent Quarter (mrq) | Dec 31, 2023 |
Profitability
| Profit Margin | -56.35% |
| Operating Margin (ttm) | -33.01% |
Management Effectiveness
| Return on Assets (ttm) | -5.07% |
| Return on Equity (ttm) | -11.53% |
Income Statement
| Revenue (ttm) | 12.77B |
| Revenue Per Share (ttm) | 154.71 |
| Quarterly Revenue Growth (yoy) | 5.30% |
| Gross Profit (ttm) | N/A |
| EBITDA | -7.92B |
| Net Income Avi to Common (ttm) | -7.19B |
| Diluted EPS (ttm) | -0.57 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 49.38B |
| Total Cash Per Share (mrq) | 552.07 |
| Total Debt (mrq) | 73.97B |
| Total Debt/Equity (mrq) | 110.72% |
| Current Ratio (mrq) | 3.79 |
| Book Value Per Share (mrq) | 746.93 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -5.27B |
| Levered Free Cash Flow (ttm) | -11.21B |
© 2024 Yahoo. All rights reserved.